3
Announcements
Trials
Browse
Landscape
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
51
Neoplasms
29
Prostatic Neoplasms
28
Head and Neck Neoplasms
15
Lung Neoplasms
14
Ovarian Neoplasms
9
Pancreatic Neoplasms
8
Urinary Bladder Neoplasms
6
Sarcoma
6
Oropharyngeal Neoplasms
6
Hematologic Neoplasms
6
Gastrointestinal Neoplasms
6
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
5
Rectal Neoplasms
5
Neoplasm Metastasis
5
Multiple Myeloma
5
Esophageal Neoplasms
5
Endometrial Neoplasms
5
Depression
5
Brain Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Polycystic Ovary Syndrome
4
Motor Activity
4
Melanoma
4
Lymphoma
4
Anxiety Disorders
4
Stomach Neoplasms
3
Pain
3
Osteosarcoma
3
Interventions
Bismuth
3
Tetracycline
2
Esomeprazole
2
Clarithromycin
2
Amoxicillin
2
Surveys and Questionnaires
1
Physical Examination
1
Phlebotomy
1
Minocycline
1
Gastroscopy
1
Furazolidone
1
Endoscopy, Digestive System
1
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastritis
×
Surveys and Questionnaires
×
1 year
×
Clear all
NCT04306939
2026-01-07
GREAT1
University of Pittsburgh
Suspended
120,000 enrolled